SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 261 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $790,156 | -14.0% | 28,660 | -6.3% | 0.01% | -9.1% |
| Q2 2023 | $919,024 | -21.1% | 30,573 | -4.9% | 0.01% | -26.7% |
| Q1 2023 | $1,164,867 | -54.4% | 32,152 | -55.1% | 0.02% | -11.8% |
| Q4 2022 | $2,556,612 | +68.5% | 71,674 | +59.9% | 0.02% | -22.7% |
| Q3 2022 | $1,517,000 | +15.4% | 44,812 | -1.4% | 0.02% | +29.4% |
| Q2 2022 | $1,315,000 | -18.8% | 45,460 | -9.2% | 0.02% | -5.6% |
| Q1 2022 | $1,619,000 | +10.5% | 50,080 | -0.3% | 0.02% | +20.0% |
| Q4 2021 | $1,465,000 | – | 50,235 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |